September 8, 2010 / 10:04 PM / 9 years ago

UPDATE 1-Santarus buys license to make diabetes drug for $5 mln

* Cycloset expected to be launched in Nov

* Santarus shrs up 1 pct after market

Sept 8 (Reuters) - Biopharmaceutical company Santarus Inc SNTS.O said it bought manufacturing rights for an approved diabetes drug for an upfront fee of $5 million.

Drugmakers S2Therapeutics Inc and VeroScience LLC signed an agreement granting Santarus exclusive rights to manufacture and commercialise Cycloset tablets in the United States.

Santarus said it expects to launch Cycloset, a prescription drug approved by the U.S. Food and Drug Administration for treating type 2 diabetes mellitus, in November.

The San Diego, California-based company also said Cycloset improves blood sugar levels without increasing cardiovascular risk.

Shares of the company, which have more than halved in value since a U.S court ruled against it in April in a patent suit on its heartburn drug, closed at $2.22 Wednesday on Nasdaq. (Reporting by Rajarshi Basu in Bangalore; Editing by Don Sebastian)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below